Journal of Thoracic Disease · 2022 · 29 citations · 13 references
MedicineRespiratory TherapyCritical Care Respiratory TherapySurvival AnalysisVentilator ManagementAcute Respiratory Distress SyndromeAcute Respiratory FailureExtracorporeal Life SupportExtracorporeal Membrane OxygenationMechanical VentilationRespiratory FailureAcute Hypoxemic Respiratory FailureCirculatory FailureIn-hospital MortalityLogistic RegressionLogistic Regression AnalysisPrimary Outcome AnalysisRespiratory Failure PrognosisRespiratory Failure Support
Background: Extracorporeal membrane oxygenation (ECMO) is an important rescue therapy for patients with refractory respiratory or circulatory failure. High cost and associated complications warrant careful case selection. The aim of this study was to investigate the outcomes and factors associated with mortality in acute hypoxemic respiratory failure patients who received ECMO support, and to externally validate preexisting ECMO survival prediction scoring systems. Methods: This retrospective study enrolled acute hypoxemic respiratory failure patients who received veno-venous (VV) or veno-arterial (VA) ECMO support at Siriraj Hospital (Bangkok, Thailand) from 2010 to 2020. All relevant baseline patient characteristics including ECMO survival prediction scores were recorded. The primary outcome was in-hospital mortality. Multivariate logistic regression analysis was employed to identify independent predictors of in-hospital mortality. Results: ratio <60, and pH <7.2 as independent predictors of in-hospital mortality. These four parameters were combined to create the SHOP (S: SOFA >14, H: hospitalize >72 hours, O: PF ratio <60, and P: pH <7.2) score. Compared with three different preexisting ECMO survival prediction scoring systems, the SHOP score had the highest area under the curve (AUC) for predicting in-hospital mortality (overall: 0.873, VV-EMCO: 0.866, and VA-EMCO: 0.891). Conclusions: ratio <60, and pH <7.2 were found to be independent predictors of in-hospital mortality. A SHOP score of 2 or higher significantly predicts in-hospital mortality in EMCO-supported patients. Trial Registration: www.clinicaltrials.gov (reg. No. NCT04031794).
13
Giles J. Peek, Miranda Mugford, Ravindranath Tiruvoipati et al. · The Lancet · 2009 · 3.4K citations
Medicine, Respiratory Therapy, Cost-effectiveness Analysis +11
Matthieu Schmidt, Michael Bailey, Jayne Sheldrake et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 855 citations
Medicine, Respiratory Therapy, Clinical Decision Support +16
Ryan P. Barbaro, Folafoluwa O. Odetola, Kelley M. Kidwell et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 768 citations
Medicine, Child Health, Pediatrics +17